StockData
Harvard Bioscience Inc logo

Harvard Bioscience Inc (HBIO) stock

HBIONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 3/3040% above fair value
$9.08+0.17 (+1.91%)

Close on Nov 17, 2026Market cap $41.33MP/E –Yield –

Harvard Bioscience r&d expenses

Research and development expenses are spending on new products and technology.

Harvard Bioscience's R&D Expenses for the twelve months ending Jun 30, 2026 was $9.09M, down 3.3% year over year. For fiscal 2025 it was $8.83M, down 15.2% from the year before. Over ten years it grew 3.2% a year on average. The highest annual figure on record is $12.33M in fiscal 2022.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$8.83M-15.2%
FY2024Dec 31, 2024$10.41M-11.5%
FY2023Dec 31, 2023$11.76M-4.6%
FY2022Dec 31, 2022$12.33M+14.2%
FY2021Dec 31, 2021$10.80M+24.3%
FY2020Dec 31, 2020$8.69M-18.9%
FY2019Dec 31, 2019$10.72M-2.5%
FY2018Dec 31, 2018$10.99M+94.7%
FY2017Dec 31, 2017$5.65M+4.7%
FY2016Dec 31, 2016$5.39M-16.0%
FY2015Dec 31, 2015$6.42M+31.6%
FY2014Dec 31, 2014$4.88M+17.5%
FY2013Dec 31, 2013$4.15M-4.4%
FY2012Dec 31, 2012$4.34M+12.1%
FY2011Dec 31, 2011$3.87M-17.0%
FY2010Dec 31, 2010$4.67M+6.2%
FY2009Dec 31, 2009$4.40M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$2.45M+12.1%
Q1 FY2026Mar 31, 2026$2.33M+0.2%
Q4 FY2025Dec 31, 2025$2.18M-6.2%
Q3 FY2025Sep 30, 2025$2.13M-16.9%
Q2 FY2025Jun 30, 2025$2.19M-16.6%
Q1 FY2025Mar 31, 2025$2.32M-19.5%
Q4 FY2024Dec 31, 2024$2.33M-26.1%
Q3 FY2024Sep 30, 2024$2.57M-7.0%
Q2 FY2024Jun 30, 2024$2.63M-11.2%
Q1 FY2024Mar 31, 2024$2.89M-0.4%
Q4 FY2023Dec 31, 2023$3.15M+10.6%
Q3 FY2023Sep 30, 2023$2.76M-0.1%
Q2 FY2023Jun 30, 2023$2.96M-15.4%
Q1 FY2023Mar 31, 2023$2.90M-10.0%
Q4 FY2022Dec 31, 2022$2.85M-3.5%
Q3 FY2022Sep 30, 2022$2.76M+3.9%
Q2 FY2022Jun 30, 2022$3.50M+29.5%
Q1 FY2022Mar 31, 2022$3.22M+29.5%
Q4 FY2021Dec 31, 2021$2.95M+25.6%
Q3 FY2021Sep 30, 2021$2.66M+36.5%
Q2 FY2021Jun 30, 2021$2.70M+42.4%
Q1 FY2021Mar 31, 2021$2.49M-0.1%
Q4 FY2020Dec 31, 2020$2.35M-11.2%
Q3 FY2020Sep 30, 2020$1.95M-24.0%
Q2 FY2020Jun 30, 2020$1.90M-31.5%
Q1 FY2020Mar 31, 2020$2.49M-9.0%
Q4 FY2019Dec 31, 2019$2.65M-13.1%
Q3 FY2019Sep 30, 2019$2.56M-7.9%
Q2 FY2019Jun 30, 2019$2.77M+0.5%
Q1 FY2019Mar 31, 2019$2.74M+13.9%
Q4 FY2018Dec 31, 2018$3.05M+99.5%
Q3 FY2018Sep 30, 2018$2.78M+80.9%
Q2 FY2018Jun 30, 2018$2.76M+112.8%
Q1 FY2018Mar 31, 2018$2.40M+86.9%
Q4 FY2017Dec 31, 2017$1.53M+32.0%
Q3 FY2017Sep 30, 2017$1.54M+17.5%
Q2 FY2017Jun 30, 2017$1.30M–
Q1 FY2017Mar 31, 2017$1.29M–
Q4 FY2016Dec 31, 2016$1.16M–
Q3 FY2016Sep 30, 2016$1.31M–

More Harvard Bioscience figures

See a number that looks wrong?